What the FDA labels say about taking them together
Asciminib and rosuvastatin
Asciminib's FDA label of November 25, 2025 names rosuvastatin in its drug interactions section; the rosuvastatin labels PlainMeds reads (2) do not name asciminib. The asciminib label: “Avoid concomitant use with rosuvastatin at all recommended doses.”
Check it at the source: the asciminib FDA label on DailyMed (effective November 25, 2025, Novartis Pharmaceuticals Corporation); the rosuvastatin FDA label on DailyMed (effective September 4, 2026, ScieGen Pharmaceuticals, Inc.).
What does the asciminib label say about rosuvastatin?
Asciminib label, drug interactionsAvoid concomitant use with rosuvastatin at all recommended doses.
Source: FDA drug label (SCEMBLIX), Novartis Pharmaceuticals Corporation, effective November 25, 2025 (SPL set e33001e7-3650-42b1-ae56-cddb5c43aa2b), via openFDA; the full label on DailyMed
What does the rosuvastatin label say about asciminib?
Rosuvastatin's label (effective September 4, 2026) and its 1 other brand-application label do not name asciminib in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Rosuvastatin), ScieGen Pharmaceuticals, Inc., effective September 4, 2026 (SPL set ee4933c5-0d97-494d-ac0f-2083e0100836), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Asciminib | Rosuvastatin | |
|---|---|---|
| Labeled for | Leukemia, lymphoma and myeloma | Heart attack and coronary artery disease, High cholesterol, High triglycerides, Stroke prevention |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | $0.0692 per tablet 40 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once